Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)
A multi-centre retrospective review of fistulizing Crohn's disease (CD) patient charts will capture data to measure health care resource utilization associated with the use of Infliximab for treatment of CD. Three health science centres/hospitals from Ontario are targeted to participate in the study, each site is expected to provide 30-40 patient charts with a target of 108 charts total.
|Study Design:||Observational Model: Cohort
Time Perspective: Retrospective
|Official Title:||Infliximab Use in Fistulizing Crohn's Disease: Impact on Health Care Resources|
- To quantify the impact of infliximab therapy on the Canadian healthcare resource utilization as expressed as incidence per year. [ Time Frame: 1 year ] [ Designated as safety issue: No ]
- To quantify the impact of infliximab therapy on healthcare resource utilization as expressed in Canadian dollars. [ Time Frame: 1 year ] [ Designated as safety issue: No ]
|Study Start Date:||April 2005|
|Study Completion Date:||September 2007|
|Primary Completion Date:||September 2007 (Final data collection date for primary outcome measure)|
Because of the difficulty of finding subjects with exactly the same disease severity, information will be recorded for the time period for up to three years before and for one year after their initial infliximab infusion for comparison of health care costs and utilization prior to infliximab and post infliximab use.
None available in the protocol. This was a chart review study, therefore no Infliximab provided during the study.
This study population was chosen from a non-probability sample.